Articles by Angie Drakulich - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Angie Drakulich

A Look Ahead at Manufacturing and Regulation

FDA talks about the changing scope of regulatory science and its effect on drug reviews, site inspections, and overall approaches.
Jan 2, 2013

FDA talks about the changing scope of regulatory science and its effect on drug reviews, site inspections, and overall approaches.

A Look Ahead for 2013

From time to time, it's important to take stock of the industry from both a retrospective and prospective point of view.
Jan 2, 2013

From time to time, it's important to take stock of the industry from both a retrospective and prospective point of view.

A Look Ahead at Manufacturing and Regulation

FDA talks about the changing scope of regulatory science and its effect on drug reviews, site inspections, overall approaches.
Jan 1, 2013

FDA talks about the changing scope of regulatory science and its effect on drug reviews, site inspections, overall approaches.

Pharma Innovation

A look at the year's leaders in innovation strategy, including the top bio/pharmaceutical companies and award recipients from AAPS, PhRMA, and CPhI.
Dec 2, 2012

A look at the year's leaders in innovation strategy, including the top bio/pharmaceutical companies and award recipients from AAPS, PhRMA, and CPhI.

Innovation in a Leading Disease Target: Alzheimer's

An interview with Eric M. Parker, Ph.D., Executive Director and Neuroscience Site Lead, Merck Research Laboratories, about the Merck BACE team's winning research.
Dec 2, 2012

An interview with Eric M. Parker, Ph.D., Executive Director and Neuroscience Site Lead, Merck Research Laboratories, about the Merck BACE team's winning research.

When Disaster Strikes at Home

PDA's strategic plan calls for maintaining valuable and effective relationships with global regulators.
Dec 2, 2012

PDA's strategic plan calls for maintaining valuable and effective relationships with global regulators.

Knowledge is Power

Global tactics that incorporate online technologies and social media are reshaping disease response.
Nov 2, 2012

Global tactics that incorporate online technologies and social media are reshaping disease response.

FDA Issues 483 to New England Compounding Center

New England Compounding Center gets 483 after linked fungal meningitis outbreak.
Oct 29, 2012

New England Compounding Center gets 483 after linked fungal meningitis outbreak.

Grad Student Research Sparks Innovation through AAPS Awards

Oct 15, 2012

At this week's AAPS 2012 Annual Meeting in Chicago, graduate students across the country are being honored for their research and work in bio/pharmaceutical innovation. Pharmaceutical Technology had the chance to talk with a few of the recipients.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
23%
To select processes for both new and legacy products
21%
Do not use QbD
23%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Click here